Tech investment company Riverside has concluded another deal, this time an investment into Bohemia Interactive Simulations, a market leader in gaming and simulation technology for military, emergency and mission-critical clients. The company already supplies technology and training services to the defense departments of the U.S., the U.K. and Australia. Its flagship product, a fully interactive [...]

Polish chimney and lining company MK Chimney Systems, owned by the Riverside Company, has been sold to the French Isotip-Joncoux Group. Riverside, which acquired the asset in 2006, exits with 2.9x cash-on-cash returns; the original equity investment came from the Riverside Europe Fund III, while the debt was provided for the transaction by WBK SA. [...]

Getting in on a recent trend in private equity buy-outs, Riverside Company is exiting Teufel Speakers through a secondary sale to HgCapital. Riverside first acquired Teufel in 2006, subsequently tripling the number of employees while doubling revenue and earnings. Though the exact purchase price hasn’t been disclosed, it has been estimated near €72.2 million based [...]

Global private equity investor Riverside has tapped its Riverside Europe Fund IV in order to acquire Tropikal, a Turkish pet food company. The acquisition marks the firm’s eleventh such deal this year. According to the terms of the transaction, Tropikal’s founders will retain a minority stake while the company CEO and management team will remain [...]

European private equity firm Riverside is seeking to find a new strategic buyer for Computer Press Media A.S. Computer Press is the leading computer books and magazines publisher in the Czech and Slovak markets, and has been part of Riverside’s portfolio since June 2005. Riverside hopes for a sale that nets them several hundred million [...]

Diatron and its shareholder Riverside Company acquired UV-Vis Metrolab S.A., an Argentinian manufacturer of automated clinical chemistry analyzers for the human medical market. Metrolab provides key contributions to the overall goal of developing an international in vitro diagnostics (“IVD”) group. UV-Vis metrolab S.A. (www.metrolab.com.ar) For more than 25 years, UV-Vis Metrolab, has designed, manufactured and [...]

The Riverside Company has acquired Novamed Ltd., an Isreali microbiology and infectious disease testing company. Novamed is an add-on to Riverside platform company Diatron, a Hungarian manufacturer of haematology analyzers and reagents. Novamed Ltd. (www.novamed.co.il) Novamed, founded in 1996, has self-developed its range of products in the field of clinical diagnostics with particular focus in [...]

The Riverside Company closed its fund Riverside Europe Fund III at €315 million. The fund was originally targeted for only €250 million. The Riverside Europe Fund III focuses on investments into niche market companies with values of €15 million and €120 million. With the expansive and strengthening market of the European Union, the fund’s strategy [...]